Jeffrey C. Jerman

4.7k citations

42 papers · 3.7k indexed · 2 hit papers · h-index 26

Impact in

Sensory Systems top 0.1%
- Ion Channels and Receptors
Endocrine and Autonomic Systems top 0.5%
- Circadian rhythm and melatonin

Papers in

Sensory Systems 14
- Ion Channels and Receptors 14
Endocrine and Autonomic Systems 12
- Circadian rhythm and melatonin 6
- Regulation of Appetite and Obesity 5

Co-authors: D Smart Stephen Brough Martin J. Gunthorpe Andrew D. Randall Janet L. Davis Darren Smart Julie Gray S. Nasir
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)British Journal of Pharmacology (9 papers)European Journal of Pharmacology (4 papers)SLAS DISCOVERY (2 papers)Nature Neuroscience (2 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Jeffrey C. Jerman

42 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

TRPV3 is a temperature-sensitive vanilloid receptor-like protein 2002 · 633 citations

Peers

Countries citing papers authored by Jeffrey C. Jerman

Since Specialization

Citations

This map shows the geographic impact of Jeffrey C. Jerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Jerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Jerman more than expected).

Fields of papers citing papers by Jeffrey C. Jerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Jerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Jerman. The network helps show where Jeffrey C. Jerman may publish in the future.

Co-authors

The 25 scholars most cited alongside Jeffrey C. Jerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey C. Jerman Line = papers co-authored together Jeffrey C. Jerman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aprepitant is a novel, selective activator of the K2P channel TRAAK Biochemical and Biophysical Research Communications ·Lucía Expósito Legarza, Emma L. Veale, Tammy Cook-Endres, Логинова Н.А., Hataitip Onbut, Jonathan M. Large, Francisco Gottifredi Neira, Lon J. Rich, Jeffrey C. Jerman, Alistair Mathie, Paul D. Wright	2021	4
2	Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3 Cellular and Molecular Life Sciences ·Trinidad Montero‐Melendez, محمدعلی متفکر آزاد, Jennifer M. Cook, Jeffrey C. Jerman, Debra L. Taylor, Mauro Perretti	2016	16
3	A High-Throughput Electrophysiology Assay Identifies Inhibitors of the Inwardly Rectifying Potassium Channel Kir7.1 SLAS DISCOVERY ·Paul D. Wright, Tineukeu Ariyanti, Weizhong Tang, M. Pasik, Nathalie Bouloc, Timothy Dale, Patricio Javier Sanmartín-Cabrera, Song Jin Il, Keysa novera Aliana, Andrew M. Blanks, Catherine Kettleborough, Jeffrey C. Jerman	2015	8
4	N-Tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1 Bioorganic & Medicinal Chemistry Letters ·Susan M. Westaway, Ali F Yahya, John B. Davis, Vicky Holland, Jeffrey C. Jerman, Stephen J. Medhurst, Harshad K. Rami, Geoffrey Stemp, Alexander J. Stevens, Mervyn Thompson, Kim Winborn, Jim Wright	2006	20
5	Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development Bioorganic & Medicinal Chemistry Letters ·Harshad K. Rami, Mervyn Thompson, Geoffrey Stemp, AKhorasanchian, Jeffrey C. Jerman, Alexander J. Stevens, Darren Smart, John Savigny, María López-Melendo, Andrew D. Randall, Martin J. Gunthorpe, John B. Davis	2006	107
6	Discovery of small molecule antagonists of TRPV1 Bioorganic & Medicinal Chemistry Letters ·Harshad K. Rami, Mervyn Thompson, Paul Wyman, Jeffrey C. Jerman, Julie Egerton, Stephen Brough, Alexander J. Stevens, Andrew D. Randall, Darren Smart, Martin J. Gunthorpe, John B. Davis	2004	50
7	Orexinergic neurons and barbiturate anesthesia Neuroscience ·Tetsuya Kushikata, Kazuyoshi Hirota, Hitoshi Yoshida, M Kudo, David G. Lambert, D Smart, Jeffrey C. Jerman, A Matsuki	2003	69
8	Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid Biochemical Pharmacology ·Christopher J. Fowler, Kent‐Olov Jonsson, Barbora Michalenková, Maia Sharuk, Tomi Järvinen, Séverine Vandevoorde, Didier M. Lambert, Jeffrey C. Jerman, Darren Smart	2003	40
9	Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors British Journal of Anaesthesia ·Jeffrey C. Jerman, Julie Gray, Stephen Brough, Lezanne Ooi, Davina E. OWEN, Janet L. Davis, D Smart	2002	30
10	TRPV3 is a temperature-sensitive vanilloid receptor-like protein Nature ·George Davey Smith, Martin J. Gunthorpe, Rosemary E. Kelsell, Philip D. Hayes, Peter J. Reilly, P. Facer, James E. Wright, Jeffrey C. Jerman, Jean‐Philippe Walhin, Lezanne Ooi, Julie Egerton, Charles Kornreich, D Smart, Andrew D. Randall, Praveen Anand, Janet L. Davis Hit paper breakdown →	2002	633
11	Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1 Nature Neuroscience ·Marcello Trevisani, D Smart, Martin J. Gunthorpe, Michele Tognetto, Mario Barbieri, Barbara Campi, Silvia Amadesi, Julie Gray, Jeffrey C. Jerman, Stephen Brough, Davina E. OWEN, George Davey Smith, Andrew D. Randall, S. Harrison, Antonio Bianchi, Janet L. Davis, Pierangelo Geppetti	2002	357
12	The physiology and pharmacology of the orexins Pharmacology & Therapeutics ·Darren Smart, Jeffrey C. Jerman	2002	83
13	Structure–activity analysis of truncated orexin-A analogues at the orexin-1 receptor Bioorganic & Medicinal Chemistry Letters ·John G. Darker, Roderick A. Porter, Drake S. Eggleston, Darren Smart, Stephen Brough, Cibele Sabido-David, Jeffrey C. Jerman	2001	58
14	1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor Bioorganic & Medicinal Chemistry Letters ·Roderick A. Porter, Wai N. Chan, Steven Coulton, Amanda Johns, Michael S. Hadley, Katherine L. Widdowson, Jeffrey C. Jerman, Stephen Brough, Martyn C. Coldwell, Darren Smart, Frances Jewitt, Philip D. Jeffrey, Nigel Austin	2001	119
15	The endogenous lipid anandamide is an agonist AT rat and human vanilloid (VR1) receptors. European Journal of Neuroscience ·Jeffrey C. Jerman, Stephen Brough, Janet L. Davis, Derek N. Middlemiss, D Smart	2000	4
16	The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1) British Journal of Pharmacology ·Jeffrey C. Jerman, Stephen Brough, Janet L. Davis, Derek N. Middlemiss, D Smart	2000	10
17	Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology British Journal of Pharmacology ·Jeffrey C. Jerman, Stephen Brough, Rab K. Prinjha, Mark H Harries, Janet L. Davis, D Smart	2000	100
18	The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) British Journal of Pharmacology ·D Smart, Martin J. Gunthorpe, Jeffrey C. Jerman, S. Nasir, Julie Gray, Chukwunonyelum Odukwe, Jon Chambers, Andrew D. Randall, Janet L. Davis Hit paper breakdown →	2000	637
19	Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan, John Evans, Michael S. Hadley, Hugh J. Herdon, Jeffrey C. Jerman, Andrew A. Parsons, Simon Read, Tania O. Stean, Mervyn Thompson, Neil Upton	1999	46
20	Characterization of the binding of [³H]‐SB‐204269, a radiolabelled form of the new anticonvulsant SB‐204269, to a novel binding site in rat brain membranes British Journal of Pharmacology ·Hugh J. Herdon, Jeffrey C. Jerman, Tania O. Stean, Derek N. Middlemiss, Wai N. Chan, Antonio Vong, John Evans, Mervyn Thompson, Neil Upton	1997	30

About Jeffrey C. Jerman

Jeffrey C. Jerman is a scholar working on Sensory Systems, Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Biochemistry, having authored 42 papers that have together received 3.7k indexed citations. Recurring topics across this work include Ion Channels and Receptors (14 papers), Ion channel regulation and function (12 papers), Sleep and Wakefulness Research (11 papers), Pain Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (7 papers), Circadian rhythm and melatonin (6 papers), Sleep and related disorders (5 papers) and Regulation of Appetite and Obesity (5 papers). The work is most often cited by research in Sensory Systems (1.6k citations), Endocrine and Autonomic Systems (1.0k citations), Cellular and Molecular Neuroscience (1.1k citations), Cognitive Neuroscience (952 citations) and Experimental and Cognitive Psychology (549 citations). Jeffrey C. Jerman has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include D Smart, Stephen Brough, Martin J. Gunthorpe, Andrew D. Randall, Janet L. Davis, Darren Smart, Julie Gray, S. Nasir, George Davey Smith and Frances Jewitt. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, British Journal of Pharmacology, European Journal of Pharmacology, SLAS DISCOVERY and Nature Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact